Sirus Pharma Marketing Pvt Ltd
About Sirus Pharma Marketing Pvt Ltd
Data last updated:
Sirus Pharma Marketing Pvt Ltd is a private limited company based in Shillong, Meghalaya, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 May 1996 and has been in existence for over 30 years.
The company is registered with the Registrar of Companies (ROC), Guwahati, under CIN U24236ML1996PTC004744. Its GSTIN is 18AACCS8840F1Z7 (Assam). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Nirmal Das (Managing Director) and Arup Das.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at G S Roadeast Khasi Hills Shillong, Meghalaya, India – 793001.
As per the financials filed for FY 2024, the company reported a revenue of ₹8.38 Lakh, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹7.02 Lakh (net margin 83.8%) and EBITDA of ₹7.37 Lakh (EBITDA margin 88%). Revenue has declined at a compounded annual rate (CAGR) of 44% over three years and 33% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sirus Pharma Marketing Pvt Ltd's registered office is in Shillong, Meghalaya. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressG S Roadeast Khasi Hills Shillong, Meghalaya, India – 793001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sirus Pharma Marketing Pvt Ltd, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Sirus Pharma Marketing Pvt Ltd
FY 2025 filings availableSirus Pharma Marketing Pvt Ltd reported revenue of ₹8.38 Lakh (up 3% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 33%. EBITDA rose 939% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.37 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 88% | ||||
| Net Profit Margin | 83.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sirus Pharma Marketing Pvt Ltd, buy the company report.
Board of directors of Sirus Pharma Marketing Pvt Ltd
Sirus Pharma Marketing has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arup Das | Director | 07 May 1996 | 30 Years 5 Months | Current |
| Nirmal Das | Managing Director | 07 May 1996 | 30 Years 5 Months | Current |
Peer comparison
Sirus Pharma Marketing Pvt Ltd is compared with the 4 companies closest to it by revenue in the Healthcare industry (Formulations, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sri Vishnu Organics Private Limited | ₹8.43 Lakh (FY 2016) | -75.0% | Thiruvallur, Tamil Nadu, India | |||
| Glorious Bio Care Private Limited | ₹8.43 Lakh (FY 2024) | 20.0% | Wadhwan, Gujarat, India | |||
| Kaytross Healthcare Limited | ₹8.41 Lakh (FY 2023) | -8.0% | Mumbai, Maharashtra, India | |||
| Sirus Pharma Marketing Pvt Ltdthis company | ₹8.38 Lakh (FY 2024) | ₹7.02 Lakh | 83.8% | 3.0% | Shillong, Meghalaya, India | |
| Richmond Biosciences Private Limited | ₹8.29 Lakh (FY 2022) | -69.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Sirus Pharma Marketing Pvt Ltd, buy the company report.
Auditor
Sirus Pharma Marketing Pvt Ltd is audited by A PAUL & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A PAUL & CO | FY 2018 | 312060E |
Shareholding
The shareholding of Sirus Pharma Marketing Pvt Ltd is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sirus Pharma Marketing Pvt Ltd, buy the company report.
Legal cases
No court or tribunal cases involving Sirus Pharma Marketing Pvt Ltd are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sirus Pharma Marketing Pvt Ltd; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sirus Pharma Marketing has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 18AACCS8840F1Z7 | Assam | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Sirus Pharma Marketing Pvt Ltd, buy the company report.
Recent activity
Sirus Pharma Marketing Pvt Ltd has 3 board changes on record since 1996: 2 appointments and 1 cessation. The latest: Namita Das ceased to be Director on 26 Mar 2019.
Frequently asked questions
Sirus Pharma Marketing is an active private limited company based in Shillong, Meghalaya, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 May 1996 (30+ years old) and is registered under CIN U24236ML1996PTC004744.
Sirus Pharma Marketing has 2 current directors:
- Nirmal Das - Managing Director
- Arup Das - Director
The latest financial statements of Sirus Pharma Marketing on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Sirus Pharma Marketing is 18AACCS8840F1Z7, registered in Assam. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Sirus Pharma Marketing is U24236ML1996PTC004744. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sirus Pharma Marketing was incorporated on 07 May 1996, making it 30+ years old. It is registered with the Registrar of Companies, Guwahati.
The peers of Sirus Pharma Marketing by revenue are Sri Vishnu Organics Private Limited, Glorious Bio Care Private Limited, Kaytross Healthcare Limited, Richmond Biosciences Private Limited, all in the Healthcare industry (Formulations, Medical and Laboratory Equipment), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Namita Das ceased to be Director on 26 Mar 2019. Arup Das was appointed as Director on 07 May 1996. Nirmal Das was appointed as Managing Director on 07 May 1996.
The registered office of Sirus Pharma Marketing is at G S Roadeast Khasi Hills Shillong, Meghalaya, India – 793001.
Sirus Pharma Marketing operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Sirus Pharma Marketing is compliant as of 15 August 2026. The company is actively filing with the Registrar of Companies.